CLINICAL_TRIALS ClinicalTrials.gov record update

A Multicenter,Randomized, Placebo-Controlled, and Double-blind Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity and Safety of Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine (Hansenula Polymorpha) in Chinese Female Aged 18-45 Years

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05584332
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:03.633588+00:00
Published At: 2023-07-21T00:00:00+00:00
Record Updated At: 2023-07-21
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Cervical Cancer", "Genital Wart", "CIN1", "CIN2", "CIN3", "Vain I", "Vain III", "Vin I", "Vin II", "Vin III", "AIS", "VAIN - Vaginal Intraepithelial Neoplasia 2"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-07-21"
protocolSection.identificationModule.nctId: "NCT05584332"
protocolSection.identificationModule.officialTitle: "A Multicenter,Randomized, Placebo-Controlled, and Double-blind Phase \u2162 Study to Evaluate the Efficacy, Immunogenicity and Safety of Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine (Hansenula Polymorpha) in Chinese Female Aged 18-45 Years"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.